Mar 12, 2026
Nvidia Bets $26 Billion On Open-Source AI Revolution

Nvidia Corp. (NASDAQ:NVDA) plans to invest $26 billion over the next five years to develop open-source artificial intelligence models, signaling a major shift in strategy beyond its core chip business. The move, disclosed in a 2025 financial filing and confirmed…

Mar 06, 2026
What’s Going on with Costco Wholesale Stock Today?

Shares of Costco Wholesale Corporation (NASDAQ:COST) traded lower before Friday’s opening bell after posting another quarterly beat in the second quarter. During the quarterly conference call, a Costco executive said the retailer has started cutting prices on some products, including…

Mar 04, 2026
KBR Wins 10-Year Contract to Power Indorama’s Global Ammonia Operations

KBR Inc. (NYSE:KBR) on Wednesday announced a 10-year catalyst supply contract from Indorama Eleme Fertilizer & Chemicals FZE for its ammonia plant portfolio. The deal will improve operational efficiency globally and marks KBR's first long-term catalyst agreement in the ammonia…

Mar 02, 2026
QXO, Apple, Exxon Mobil and a Financial Stock: CNBC’s ‘Final Trades’

On CNBC's “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked QXO, Inc. (NYSE:QXO) following the release of quarterly earnings. QXO reported fourth-quarter earnings of 2 cents per share on Feb.…

Feb 27, 2026
Eric Trump Says He Believes in BTC ‘Long Term’

Eric Trump, co-founder and Chief Strategy Officer of American Bitcoin Corp. (NASDAQ:ABTC), said Thursday that the company’s core long-term strategy is to increase Bitcoin (CRYPTO: BTC) on its balance sheet. ‘We Believe In Bitcoin In The Long Term’ During American Bitcoin’s fourth-quarter…

Feb 23, 2026
Gilead Buys Arcellx to Fast-Track Next-Gen Myeloma Drug

On Monday, Gilead Sciences Inc. (NASDAQ:GILD) announced it is acquiring Arcellx Inc. (NASDAQ:ACLX) to enhance its long-term oncology prospects. Gilead currently owns approximately 11.5% of Arcellx’s outstanding common stock. Multi-Billion Dollar Cancer Deal Gilead Sciences on Monday agreed to acquire…

Subscribe to get market latest alerts

Subscribe and receive daily afternoon commentary and trade opportunities
focused on income setups.

*By submitting your information you agree to the terms of our Privacy Policy. You will receive the income setups newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.